estradiol 0.075 MG/Day Twice Weekly Transdermal System
- RxCUI
- 1149632
- RxNorm name
- estradiol 0.075 MG/Day Twice Weekly Transdermal System
- Display name
- estradiol 0.075 MG/Day Twice Weekly Transdermal System
- Full name
- estradiol 0.075 MG/Day Twice Weekly Transdermal System
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | d28bec8f-762e-4f05-a20d-96a42970d6a7 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| DOTTI | ESTRADIOL | Bryant Ranch Prepack | b119df4a-c514-4804-b1a8-b09c6058e80d | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Amneal Pharmaceuticals NY LLC | d4259bb8-91f8-4587-8ceb-35d44145aec0 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| LYLLANA | ESTRADIOL | Amneal Pharmaceuticals LLC | 09c472c6-a38a-4a3d-b048-6fefd52e2ad3 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Amneal Pharmaceuticals NY LLC | 0500ee9b-bf4a-4432-9afe-20a7d60a6fe5 | 2024-05-14 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| DOTTI | ESTRADIOL | Amneal Pharmaceuticals LLC | 53016d30-6b5f-49da-ac16-85ef415a5805 | 2024-05-14 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Noven Therapeutics, LLC | bf185599-2138-4083-9c52-2b95dce09ae0 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Zydus Pharmaceuticals USA Inc. | 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | 2024-03-15 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Sandoz Inc | c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | 2024-02-29 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Minivelle | ESTRADIOL | Noven Therapeutics, LLC | 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | 2024-02-22 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Vivelle-Dot | ESTRADIOL | Sandoz Inc | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | 1149632 |
| Estradiol | ESTRADIOL | Zydus Lifesciences Limited | b79fd5ea-962f-491c-b670-40efe42ccf79 | 2022-12-07 | 1149632 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b119df4a-c514-4804-b1a8-b09c6058e80d | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 102 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240812 |
| b119df4a-c514-4804-b1a8-b09c6058e80d | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 102 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240812 |
| b119df4a-c514-4804-b1a8-b09c6058e80d | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 102 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240812 |
| b119df4a-c514-4804-b1a8-b09c6058e80d | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 102 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240812 |
| b119df4a-c514-4804-b1a8-b09c6058e80d | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 102 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240812 |
| 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 19 | These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240222 |
| 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 19 | These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240222 |
| 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 19 | These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240222 |
| 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 19 | These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240222 |
| 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 19 | These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240222 |
| 0500ee9b-bf4a-4432-9afe-20a7d60a6fe5 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 17 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1996 | 20240514 |
| 0500ee9b-bf4a-4432-9afe-20a7d60a6fe5 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 17 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1996 | 20240514 |
| 0500ee9b-bf4a-4432-9afe-20a7d60a6fe5 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 17 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1996 | 20240514 |
| 0500ee9b-bf4a-4432-9afe-20a7d60a6fe5 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 17 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1996 | 20240514 |
| 0500ee9b-bf4a-4432-9afe-20a7d60a6fe5 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 17 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1996 | 20240514 |
| 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 17 | These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20231117 |
| 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 17 | These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20231117 |
| 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 17 | These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20231117 |
| 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 17 | These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20231117 |
| 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 17 | These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20231117 |
| 09c472c6-a38a-4a3d-b048-6fefd52e2ad3 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 15 | These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240515 |
| 09c472c6-a38a-4a3d-b048-6fefd52e2ad3 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 15 | These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240515 |
| 09c472c6-a38a-4a3d-b048-6fefd52e2ad3 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 15 | These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240515 |
| 09c472c6-a38a-4a3d-b048-6fefd52e2ad3 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 15 | These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240515 |
| 09c472c6-a38a-4a3d-b048-6fefd52e2ad3 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 15 | These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240515 |
| d28bec8f-762e-4f05-a20d-96a42970d6a7 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 14 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1996 | 20250617 |
| d28bec8f-762e-4f05-a20d-96a42970d6a7 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 14 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1996 | 20250617 |
| d28bec8f-762e-4f05-a20d-96a42970d6a7 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 14 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1996 | 20250617 |
| d28bec8f-762e-4f05-a20d-96a42970d6a7 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 14 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1996 | 20250617 |
| d28bec8f-762e-4f05-a20d-96a42970d6a7 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 14 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1996 | 20250617 |
| d4259bb8-91f8-4587-8ceb-35d44145aec0 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1975 | 20240515 |
| d4259bb8-91f8-4587-8ceb-35d44145aec0 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1975 | 20240515 |
| d4259bb8-91f8-4587-8ceb-35d44145aec0 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1975 | 20240515 |
| d4259bb8-91f8-4587-8ceb-35d44145aec0 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1975 | 20240515 |
| d4259bb8-91f8-4587-8ceb-35d44145aec0 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1975 | 20240515 |
| c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1996 | 20240229 |
| c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1996 | 20240229 |
| c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1996 | 20240229 |
| c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1996 | 20240229 |
| c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 11 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1996 | 20240229 |
| 53016d30-6b5f-49da-ac16-85ef415a5805 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 10 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240514 |
| 53016d30-6b5f-49da-ac16-85ef415a5805 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 10 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240514 |
| 53016d30-6b5f-49da-ac16-85ef415a5805 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 10 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240514 |
| 53016d30-6b5f-49da-ac16-85ef415a5805 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 10 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240514 |
| 53016d30-6b5f-49da-ac16-85ef415a5805 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 10 | These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 1996 | 20240514 |
| f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 7 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1975 | 20250623 |
| f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 7 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1975 | 20250623 |
| f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 7 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1975 | 20250623 |
| f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 7 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1975 | 20250623 |
| f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 7 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 1975 | 20250623 |
| bf185599-2138-4083-9c52-2b95dce09ae0 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 6 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1975 | 20240405 |
| bf185599-2138-4083-9c52-2b95dce09ae0 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 6 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1975 | 20240405 |
| bf185599-2138-4083-9c52-2b95dce09ae0 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 6 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1975 | 20240405 |
| bf185599-2138-4083-9c52-2b95dce09ae0 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 6 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1975 | 20240405 |
| bf185599-2138-4083-9c52-2b95dce09ae0 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 6 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 1975 | 20240405 |
| 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 4 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 1996 | 20240315 |
| 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 4 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 1996 | 20240315 |
| 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 4 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 1996 | 20240315 |
| 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 4 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 1996 | 20240315 |
| 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 4 | These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 1996 | 20240315 |
| b79fd5ea-962f-491c-b670-40efe42ccf79 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 1 | ESTRADIOL transdermal system, USP (TWICE-WEEKLY) | 20221207 |
| b79fd5ea-962f-491c-b670-40efe42ccf79 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 1 | ESTRADIOL transdermal system, USP (TWICE-WEEKLY) | 20221207 |
| b79fd5ea-962f-491c-b670-40efe42ccf79 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 1 | ESTRADIOL transdermal system, USP (TWICE-WEEKLY) | 20221207 |
| b79fd5ea-962f-491c-b670-40efe42ccf79 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 1 | ESTRADIOL transdermal system, USP (TWICE-WEEKLY) | 20221207 |
| b79fd5ea-962f-491c-b670-40efe42ccf79 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 1 | ESTRADIOL transdermal system, USP (TWICE-WEEKLY) | 20221207 |
| 03ab0226-b494-4607-8e8b-7381082fa780 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 1 | Vivelle-Dot | 20120217 |
| 03ab0226-b494-4607-8e8b-7381082fa780 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 1 | Vivelle-Dot | 20120217 |
| 03ab0226-b494-4607-8e8b-7381082fa780 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 1 | Vivelle-Dot | 20120217 |
| 03ab0226-b494-4607-8e8b-7381082fa780 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 1 | Vivelle-Dot | 20120217 |
| 03ab0226-b494-4607-8e8b-7381082fa780 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 1 | Vivelle-Dot | 20120217 |